Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

High Risk

Score: 80/100

Failure Rate

33.3%

1 terminated/withdrawn out of 3 trials

Success Rate

50.0%

-36.5% vs industry average

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

200%

2 of 1 completed trials have results

Key Signals

1 recruiting2 with results

Enrollment Performance

Analytics

N/A
3(100.0%)
3Total
N/A(3)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (3)

Showing 3 of 3 trials
NCT05677100Not ApplicableRecruiting

Diuretics Alone vs. Aortix Endovascular Device for Acute Heart Failure

Role: lead

NCT04999163Not ApplicableTerminated

Aortix Therapy for Perioperative Reduction of Kidney Injury

Role: lead

NCT04145635Not ApplicableCompleted

The Aortix CRS Pilot Study

Role: lead

All 3 trials loaded